Michael Tekle

Dr. Michael Tekle

Karolinska Institutet

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
CSCheng Schwank-Xu
Cheng Schwank-Xu
EFElisabete Forsberg
Elisabete Forsberg
MBMagnus Bentinger
Magnus Bentinger
AZAllan Zhao
Allan Zhao
IAIshrath Ansurudeen
Ishrath Ansurudeen
MTMichael Tekle
Michael Tekle
Mitochondrial dysfunction in type 2 diabetes leads to oxidative stress, which drives disease progression and diabetes complications. L-carnosine, an endogenous dipeptide, improves metabolic control, wound healing and kidney function in animal models of type 2 diabetes. Coenzyme Q (CoQ), a component of the mitochondrial electron transport chain, possesses similar protective effects on diabetes complications. We aimed to study the effect of carnosine on CoQ, and assess any synergistic effects of carnosine and CoQ on improved mitochondrial function in a mouse model of type 2 diabetes. Carnosine enhanced CoQ gene expression and increased hepatic CoQ biosynthesis in db/db mice, a type 2 diabetes model. Co-administration of Carnosine and CoQ improved mitochondrial function, lowered ROS formation and reduced signs of oxidative stress. Our work suggests that carnosine exerts beneficial effects on hepatic CoQ synthesis and when combined with CoQ, improves mitochondrial function and cellular redox balance in the liver of diabetic mice. (4) Conclusions: L-carnosine has beneficial effects on oxidative stress both alone and in combination with CoQ on hepatic mitochondrial function in an obese type 2 diabetes mouse model.

2 July 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
GDGustav Dallner
Gustav Dallner
MBMagnus Bentinger
Magnus Bentinger
SHShafaat Hussain
Shafaat Hussain
ISIndranil Sinha
Indranil Sinha
JYJiangning Yang
Jiangning Yang
MTMichael Tekle
Michael Tekle
Hyperglycemia, hyperlipidemia, and adiposity are the main factors that cause inflammation in type 2 diabetes due to excessive ROS production, leading to late complications. To counteract the effects of increased free radical production, we searched for a compound with effective antioxidant properties that can induce coenzyme Q biosynthesis without affecting normal cellular functions. Tocotrienols are members of the vitamin E family, well-known as efficient antioxidants that are more effective than tocopherols. Deh-T3β is a modified form of the naturally occurring tocotrienol-β. The synthesis of this compound involves the sequential modification of geranylgeraniol. In this study, we investigated the effects of this compound in different experimental models of diabetes complications. Deh-T3β was found to possess multifaceted capacities. In addition to enhanced wound healing, deh-T3β improved kidney and liver functions, reduced liver steatosis, and improved heart recovery after ischemia and insulin sensitivity in adipose tissue in a mice model of type 2 diabetes. Deh-T3β exerts these positive effects in several organs of the diabetic mice without reducing the non-fasting blood glucose levels, suggesting that both its antioxidant properties and improvement in mitochondrial function are involved, which are central to reducing diabetes complications.

7 August 2020
Verified
Book Chapter
Closed access
PDF file
MBMagnus Bentinger
Magnus Bentinger
GDGustav Dallner
Gustav Dallner
KBKerstin Brismar
Kerstin Brismar
ESEwa Swiezewska
Ewa Swiezewska
MTMichael Tekle
Michael Tekle